Finding genetic modifiers of cystic fibrosis
- PMID: 16207854
- DOI: 10.1056/NEJMe058185
Finding genetic modifiers of cystic fibrosis
Comment on
-
Genetic modifiers of lung disease in cystic fibrosis.N Engl J Med. 2005 Oct 6;353(14):1443-53. doi: 10.1056/NEJMoa051469. N Engl J Med. 2005. PMID: 16207846
Similar articles
-
Genetic modifiers of lung disease in cystic fibrosis.N Engl J Med. 2005 Oct 6;353(14):1443-53. doi: 10.1056/NEJMoa051469. N Engl J Med. 2005. PMID: 16207846
-
Genetic modifiers in cystic fibrosis.N Engl J Med. 2006 Jan 5;354(1):88-90; author reply 88-90. N Engl J Med. 2006. PMID: 16395827 No abstract available.
-
Genetic modifiers in cystic fibrosis.N Engl J Med. 2006 Jan 5;354(1):88-90; author reply 88-90. doi: 10.1056/NEJMc052980. N Engl J Med. 2006. PMID: 16394309 No abstract available.
-
Gene modifiers of lung disease.Curr Opin Pulm Med. 2006 Nov;12(6):416-21. doi: 10.1097/01.mcp.0000245707.59138.40. Curr Opin Pulm Med. 2006. PMID: 17053491 Review.
-
Modifier genetics: cystic fibrosis.Annu Rev Genomics Hum Genet. 2005;6:237-60. doi: 10.1146/annurev.genom.6.080604.162254. Annu Rev Genomics Hum Genet. 2005. PMID: 16124861 Review.
Cited by
-
Complex two-gene modulation of lung disease severity in children with cystic fibrosis.J Clin Invest. 2008 Mar;118(3):1040-9. doi: 10.1172/JCI33754. J Clin Invest. 2008. PMID: 18292811 Free PMC article.
-
Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.J Appl Genet. 2010;51(3):323-30. doi: 10.1007/BF03208862. J Appl Genet. 2010. PMID: 20720307
-
LMTK2 switches on canonical TGF-β1 signaling in human bronchial epithelial cells.Am J Physiol Lung Cell Mol Physiol. 2024 Nov 1;327(5):L769-L782. doi: 10.1152/ajplung.00034.2024. Epub 2024 Sep 24. Am J Physiol Lung Cell Mol Physiol. 2024. PMID: 39316683
-
Identifying modifier loci in existing genome scan data.Ann Hum Genet. 2008 Sep;72(Pt 5):670-5. doi: 10.1111/j.1469-1809.2008.00449.x. Epub 2008 May 16. Ann Hum Genet. 2008. PMID: 18494837 Free PMC article.
-
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20896-901. doi: 10.1073/pnas.0707731105. Epub 2007 Dec 17. Proc Natl Acad Sci U S A. 2007. PMID: 18087043 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical